Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity

被引：0
|
作者：
Jiawei Yue
Hui Guo
Peng Xu
Jinhong Ma
Weifeng Shi
Yumin Wu
机构：
[1] The Third Affiliated Hospital of Soochow University,Department of Orthopaedics
[2] The Third Affiliated Hospital of Soochow University,Department of Laboratory Medicine
[3] Institute of Nano and Soft Materials (FUNSOM) College of Nano Science &Technology (CNST) Suzhou,Jiangsu Key Laboratory for Carbon
来源：
Cancer Immunology, Immunotherapy | / 73卷
关键词：
Group 2 innate lymphoid cells; Interleukin-33; Cancer immunotherapy; Mature ILC2; Programmed cell death protein-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
    Li, Baoqi
    Fang, Tianliang
    Li, Yuan
    Xue, Tianyuan
    Zhang, Zhirang
    Li, Liyan
    Meng, Fanqiang
    Wang, Jinqiang
    Hou, Linlin
    Liang, Xin
    Zhang, Xudong
    Gu, Zhen
    NANO TODAY, 2022, 46
  • [32] Engineered T cell extracellular vesicles displaying PD-1 boost anti-tumor immunity
    Li, Baoqi
    Fang, Tianliang
    Li, Yuan
    Xue, Tianyuan
    Zhang, Zhirang
    Li, Liyan
    Meng, Fanqiang
    Wang, Jinqiang
    Hou, Linlin
    Liang, Xin
    Zhang, Xudong
    Gu, Zhen
    Nano Today, 2022, 46
  • [33] PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity
    Koller, Paul
    Baran, Natalia
    Harutyunyan, Karine
    Cavazos, Antonio
    Mallampati, Saradhi
    Chin, Renee L.
    Jiang, Zhou
    Sun, Xian
    Lee, Heng-Huan
    Hsu, Jennifer L.
    Williams, Patrick
    Huang, Xuelin
    Curran, Michael A.
    Hung, Mien-Chie
    Konopleva, Marina
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (10)
  • [34] D-mannose targets PD-1 to lysosomal degradation and enhances T cell-mediated anti-tumor immunity
    Dong, Wenjing
    Lin, Mingen
    Zhang, Ruonan
    Sun, Xue
    Li, Hongchen
    Liu, Tianshu
    Xu, Yanping
    Lv, Lei
    CANCER LETTERS, 2024, 591
  • [35] Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer
    Xiao, Roy
    Allen, Clint T.
    Tran, Linda
    Patel, Priya
    Park, So-Jin
    Chen, Zhong
    Van Waes, Carter
    Schmitt, Nicole C.
    ONCOIMMUNOLOGY, 2018, 7 (09):
  • [36] Therapeutic IL-33 enhances the antigen presentation function of ILC2s to exert anti-tumor immune activity
    Liu, Jie
    Feng, Zhenchu
    Wei, Hongyan
    Li, Chang
    Li, Xiaoshi
    Chen, Wenlong
    Ke, Yixi
    Wang, Minjun
    Liu, Lantian
    Zheng, Cunni
    Liu, Quan
    CANCER RESEARCH, 2024, 84 (06)
  • [37] SEX-LINKED DIFFERENCES IN OBESITY MARKEDLY IMPACT THE ANTI-TUMOR EFFICACY OF PD-1 BLOCKADE
    Vick, Logan
    Wang, Ziming
    Collins, Craig
    Khuat, Lam
    Dunai, Cordelia
    Stoffel, Kevin
    Yendamuri, Sai
    Mukherjee, Sarbajit
    Rosario, Spencer
    Canter, Robert
    Monjazeb, Arta
    Murphy, William
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A560 - A560
  • [38] Dual angiopoietin-2/VEGFA inhibition elicits anti-tumor immunity that is enhanced by PD1 blockade
    Schmittnaegel, M.
    Rigamonti, N.
    Kadioglu, E.
    Cassara, A.
    Wyser, Rmili C.
    Kiialainen, A.
    Kienast, Y.
    Mueller, H. J.
    Ooi, C. H.
    Laoui, D.
    De Palma, M.
    SWISS MEDICAL WEEKLY, 2017, 147 : 49S - 49S
  • [39] Dual cIAP1/XIAP inhibitor ASTX660 synergizes with radiation therapy and PD-1 blockade to enhance anti-tumor immunity
    Xiao, Roy
    Allen, Clint
    Tran, Linda
    Park, So-Jin
    Chen, Zhong
    Van Waes, Carter
    Schmitt, Nicole
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [40] Dual Angiopoietin-2/VEGFA Inhibition Elicits Anti-Tumor Immunity That is Enhanced by PD1 Blockade
    Schmittnaegel, M.
    Rigamonti, N.
    Kadioglu, E.
    Cassara, A.
    Rmili, C. Wyser
    Kiialainen, A.
    Kienast, Y.
    Mueller, H. -J.
    Ooi, C. -H.
    Laoui, D.
    De Palma, M.
    JOURNAL OF VASCULAR RESEARCH, 2017, 54 : 4 - 4
12345